West Pharmaceutical’s 31.93 P/E and D Value Grade Lag Align Technology
West Pharmaceutical Services’ forward P/E of 31.93, PEG of 2.71 and P/B of 5.70 yield a Value grade D versus Align Technology’s 16.92 P/E, 1.68 PEG and 3.35 P/B for a Value grade B. Both stocks hold Zacks Rank #2 (Buy) after positive earnings estimate revisions.
1. Zacks Rank Signals Improving Outlook
West Pharmaceutical Services and Align Technology both carry a Zacks Rank #2 (Buy), reflecting positive revisions to earnings estimates and signaling an improving earnings outlook for each company.
2. WST Valuation Metrics Reveal Premium Pricing
WST trades at a forward P/E of 31.93, PEG ratio of 2.71 and P/B of 5.70, resulting in a Value grade of D under Zacks’ Style Scores. In contrast, Align Technology’s forward P/E of 16.92, PEG of 1.68 and P/B of 3.35 earn a Value grade of B.
3. Value Comparison Favors Align Technology
Based on these valuation metrics, Align Technology presents a more attractive entry point for value investors. WST’s higher multiples suggest that its stock may be less undervalued despite an improving earnings outlook.